B. Martone

A Phase II Study of sEphB4-HSA in Metastatic Castration-Resistant Prostate Cancer.

S. Abdulkadir, W. Stadler, A. Morgans, 2022, Clinical genitourinary cancer.

A phase II trial of interleukin‐2 in myelodysplastic syndromes

J. Sosman, W. Stock, P. Stiff, 1998, British journal of haematology.

A multi-institutional phase II trial of a novel inpatient schedule of continuous interleukin-2 with interferon alpha-2b in advanced renal cell carcinoma: major durable responses in a less highly selected patient population.

J. Sosman, T. Kuzel, S. Fisher, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Pilot trial of interleukin-2 with granulocyte colony-stimulating factor for the mobilization of progenitor cells in advanced breast cancer patients undergoing high-dose chemotherapy: expansion of immune effectors within the stem-cell graft and post-stem-cell infusion.

J. Sosman, R. Hoffman, W. Stock, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Novel Use of Targeted Therapy via PARP-Inhibition in a Rare Form of Papillary Renal Cell Carcinoma: A Case Report and Literature Review.

Ximing J. Yang, T. Kuzel, Savita Bhalla, 2016, Clinical genitourinary cancer.

A Pilot Study of Denileukin Diftitox (DD) in Combination With High-dose Interleukin-2 (IL-2) for Patients With Metastatic Renal Cell Carcinoma (RCC)

A. Rademaker, N. Smith, T. Kuzel, 2010, Journal of immunotherapy.

A Phase I Study of High-Dose Calcitriol in Combination with Temozolomide for Patients with Metastatic Melanoma

A. Rademaker, T. Kuzel, Erin M Pettijohn, 2014, Journal of personalized medicine.

Daily subcutaneous ultra-low-dose interleukin 2 with daily low-dose interferon-alpha in patients with advanced renal cell carcinoma.

J. Sosman, R. Flanigan, E. Gaynor, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

In vivo Generation of Angiostatin Isoforms by Administration of a Plasminogen Activator and a Free Sulfhydryl Donor: A Phase I Study of an Angiostatic Cocktail of Tissue Plasminogen Activator and Mesna

Hao Wang, A. Rademaker, T. Kuzel, 2005, Clinical Cancer Research.